Cadila Healthcare Ltd - 532321 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper cutting with regard to publication of extracts of unaudited financial results for the quarter/ half year ended on September 30, 202130-10-2021
30-10-2021
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Q2 FY22 post results conference call details29-10-2021
Cadila Healthcare Q2 PAT up by 6% YoY to Rs 597 cr, revenue up 3%
The company's EBIDTA margin for the quarter was 22.7 per cent, up by 50 basis points29-10-2021
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation on unaudited financial results for the quarter / half year ended September 30, 202129-10-2021
Q2FY22 Quarterly Result Announced for Cadila Healthcare Ltd.
Highlights: Zydus Cadila posts consolidated revenues of Rs. 3785 crores in Q2, up 3% on a y-o-y basis. Earnings before Interest, Depreciation and Tax (EBIDTA) for the quarter was Rs. 861 crores, up by 6% y-o-y. The EBIDTA margin for the quarter was 22.7%, an improvement of 50 basis points on a y-o-y basis. Profit After Tax (PAT) stood at Rs. 597 crores, up 6% on a y-o-y basis. Result PDF29-10-2021
CADILA HEALTHCARE LTD. - 532321 - Unaudited Financial Results For The Quarter / Half Year Ended On September 30, 2021
Unaudited Financial Results for the quarter / half year ended on September 30, 202129-10-2021
Zydus Cadila vaccine price finalised, rollout to begin soon: Mansukh Mandaviya
The price of Zydus Cadila vaccine is expected to be higher than Covishield and Covaxin27-10-2021
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Post results conference call23-10-2021
Cadila Healthcare Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release dated 22.10.202122-10-2021
CADILA HEALTHCARE LTD. - 532321 - Board Meeting Intimation for Board Meeting Scheduled On 29/10/2021
CADILA HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2021 ,inter alia, to consider and approve Board Meeting scheduled to approve the unaudited financial results for the quarter / half year ended on September 30, 202120-10-2021